The specific mutation RAC1 R29S, identified in up to 9% of sun-exposed melanomas, results in its constitutive activation promoting downstream signaling, driving cancer cell proliferation and survival, cytoskeleton remodeling, and invasion. The gene discussed is RAC1; the disease is melanoma.